SG164382A1 - Use of azithromycin for the production of a medicament for treatment of ocular infections - Google Patents
Use of azithromycin for the production of a medicament for treatment of ocular infectionsInfo
- Publication number
- SG164382A1 SG164382A1 SG201005298-3A SG2010052983A SG164382A1 SG 164382 A1 SG164382 A1 SG 164382A1 SG 2010052983 A SG2010052983 A SG 2010052983A SG 164382 A1 SG164382 A1 SG 164382A1
- Authority
- SG
- Singapore
- Prior art keywords
- azithromycin
- medicament
- treatment
- production
- ocular infections
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0504069A FR2884716B1 (fr) | 2005-04-22 | 2005-04-22 | Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires |
Publications (1)
Publication Number | Publication Date |
---|---|
SG164382A1 true SG164382A1 (en) | 2010-09-29 |
Family
ID=35445697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG201005298-3A SG164382A1 (en) | 2005-04-22 | 2006-04-21 | Use of azithromycin for the production of a medicament for treatment of ocular infections |
Country Status (25)
Country | Link |
---|---|
US (2) | US20060252711A1 (ja) |
EP (1) | EP1877066A1 (ja) |
JP (1) | JP2008536908A (ja) |
KR (1) | KR20080008377A (ja) |
CN (1) | CN101163486B (ja) |
AR (1) | AR053591A1 (ja) |
AU (1) | AU2006238595A1 (ja) |
BR (1) | BRPI0608375A2 (ja) |
CA (1) | CA2603833A1 (ja) |
EA (1) | EA200702295A1 (ja) |
FR (1) | FR2884716B1 (ja) |
HK (1) | HK1119064A1 (ja) |
IL (1) | IL186092A (ja) |
JO (1) | JO3448B1 (ja) |
MA (1) | MA29467B1 (ja) |
MX (1) | MX2007013054A (ja) |
MY (1) | MY169533A (ja) |
NO (1) | NO20075943L (ja) |
PE (1) | PE20070157A1 (ja) |
SG (1) | SG164382A1 (ja) |
TN (1) | TNSN07370A1 (ja) |
TW (1) | TWI430799B (ja) |
UA (1) | UA94708C2 (ja) |
WO (1) | WO2006111844A1 (ja) |
ZA (1) | ZA200709872B (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2098219A1 (en) | 2008-03-05 | 2009-09-09 | PARI Pharma GmbH | Macrolide compositions having improved taste and stability |
US8106111B2 (en) | 2009-05-15 | 2012-01-31 | Eastman Chemical Company | Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions |
TWI572352B (zh) * | 2012-03-01 | 2017-03-01 | 波麥堤克藥學Smt有限公司 | 用於製備具中鏈長度之脂肪酸的三酸甘油酯之方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6241124B1 (en) * | 1996-12-09 | 2001-06-05 | Bausch & Lomb Incorporated | Single-use container |
EP0925789B2 (en) * | 1997-12-02 | 2009-06-17 | Pfizer Products Inc. | Use of azithromycin in the topical treatment of ocular infections |
US6861411B1 (en) * | 1997-12-02 | 2005-03-01 | Pfizer, Inc. | Method of treating eye infections with azithromycin |
US7056893B2 (en) * | 1999-03-31 | 2006-06-06 | Insite Vision, Inc. | Topical treatment for prevention of ocular infections |
US6239113B1 (en) * | 1999-03-31 | 2001-05-29 | Insite Vision, Incorporated | Topical treatment or prevention of ocular infections |
FR2823441B1 (fr) * | 2001-04-12 | 2004-09-10 | Thea Lab | Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation |
-
2005
- 2005-04-22 FR FR0504069A patent/FR2884716B1/fr active Active
-
2006
- 2006-04-16 JO JOP/2006/0102A patent/JO3448B1/ar active
- 2006-04-18 TW TW095113740A patent/TWI430799B/zh active
- 2006-04-20 MY MYPI20061806A patent/MY169533A/en unknown
- 2006-04-20 AR ARP060101560A patent/AR053591A1/es unknown
- 2006-04-20 PE PE2006000412A patent/PE20070157A1/es not_active Application Discontinuation
- 2006-04-21 WO PCT/IB2006/000963 patent/WO2006111844A1/fr active Application Filing
- 2006-04-21 MX MX2007013054A patent/MX2007013054A/es not_active Application Discontinuation
- 2006-04-21 BR BRPI0608375-7A patent/BRPI0608375A2/pt not_active Application Discontinuation
- 2006-04-21 KR KR1020077027244A patent/KR20080008377A/ko not_active Application Discontinuation
- 2006-04-21 JP JP2008507188A patent/JP2008536908A/ja active Pending
- 2006-04-21 CA CA002603833A patent/CA2603833A1/fr not_active Abandoned
- 2006-04-21 EA EA200702295A patent/EA200702295A1/ru unknown
- 2006-04-21 UA UAA200713028A patent/UA94708C2/ru unknown
- 2006-04-21 SG SG201005298-3A patent/SG164382A1/en unknown
- 2006-04-21 EP EP06744536A patent/EP1877066A1/fr not_active Ceased
- 2006-04-21 CN CN2006800135229A patent/CN101163486B/zh active Active
- 2006-04-21 AU AU2006238595A patent/AU2006238595A1/en not_active Abandoned
- 2006-04-21 US US11/408,161 patent/US20060252711A1/en not_active Abandoned
-
2007
- 2007-09-20 IL IL186092A patent/IL186092A/en active IP Right Grant
- 2007-10-01 TN TNP2007000370A patent/TNSN07370A1/fr unknown
- 2007-11-15 ZA ZA200709872A patent/ZA200709872B/xx unknown
- 2007-11-19 NO NO20075943A patent/NO20075943L/no not_active Application Discontinuation
- 2007-11-21 MA MA30395A patent/MA29467B1/fr unknown
-
2008
- 2008-09-30 HK HK08110973.2A patent/HK1119064A1/xx unknown
-
2009
- 2009-09-08 US US12/555,509 patent/US20100069315A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN101163486B (zh) | 2011-11-30 |
MA29467B1 (fr) | 2008-05-02 |
EP1877066A1 (fr) | 2008-01-16 |
JO3448B1 (ar) | 2020-07-05 |
MX2007013054A (es) | 2008-01-14 |
TWI430799B (zh) | 2014-03-21 |
TW200716142A (en) | 2007-05-01 |
FR2884716B1 (fr) | 2009-08-21 |
IL186092A0 (en) | 2008-01-20 |
MY169533A (en) | 2019-04-22 |
EA200702295A1 (ru) | 2008-04-28 |
WO2006111844A1 (fr) | 2006-10-26 |
IL186092A (en) | 2016-05-31 |
HK1119064A1 (en) | 2009-02-27 |
FR2884716A1 (fr) | 2006-10-27 |
ZA200709872B (en) | 2008-09-25 |
CN101163486A (zh) | 2008-04-16 |
AR053591A1 (es) | 2007-05-09 |
PE20070157A1 (es) | 2007-03-09 |
BRPI0608375A2 (pt) | 2010-08-31 |
TNSN07370A1 (fr) | 2009-03-17 |
AU2006238595A1 (en) | 2006-10-26 |
US20060252711A1 (en) | 2006-11-09 |
KR20080008377A (ko) | 2008-01-23 |
CA2603833A1 (fr) | 2006-10-26 |
US20100069315A1 (en) | 2010-03-18 |
UA94708C2 (ru) | 2011-06-10 |
JP2008536908A (ja) | 2008-09-11 |
NO20075943L (no) | 2008-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY147478A (en) | Microbiologically stabilised beer | |
TW200716519A (en) | Benzoyl-substituted serineamides | |
MX2008014101A (es) | Acidos carboxilicos sustituidos con 4,5-difenil-pirimidinilamino, metodo para su produccion y su uso como medicamentos. | |
UY29636A1 (es) | 2,4-diamino-pirimidinas como inhibidores de aurora | |
WO2007067559A3 (en) | Antibacterial agents | |
UY28702A1 (es) | Derivados de quinazolina | |
UA86399C2 (ru) | Применение 2,5 дигидроксибензолсульфоновой кислоты для изготовления лекарства, которые применяют для лечения болезней, зависимых от ангиогенеза | |
ATE380188T1 (de) | Substituierte chinolone | |
ATE531703T1 (de) | Benzochromenderivate | |
MX2009006325A (es) | Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales. | |
DE502005006427D1 (de) | Substituierte azachinazoline mit antiviraler wirkung | |
BRPI0712312A2 (pt) | Composto, processo para a produção do mesmo, composição farmacêutica, agente antimicrobiano, agente anti-mrsa, método para a prevenção ou o tratamento de uma doença infecciosa, e, uso do composto | |
SG164382A1 (en) | Use of azithromycin for the production of a medicament for treatment of ocular infections | |
CL2011001829A1 (es) | 3'-n-desmetil-4''-o-(2-dietilaminoetanoil)-6-o-metil-9a-aza-9a-homoeritromicina a, sus sales y formas cristalinas 1, 2 y 3; proceso de preparacion; uso para tratar enfermedades inflamatorias; composicion farmaceutica; y composicion que ademas comprende otro compuesto activo. | |
ATE407126T1 (de) | Herstellung von (s)-4-fluormethyl-dihydro-furan-2-on | |
ATE410443T1 (de) | Heterocyclyl-substituierte nonadepsipeptide | |
UY31204A1 (es) | Derivados de macrolactona | |
ATE524488T1 (de) | Lysobactinamide | |
FR2905600B1 (fr) | Traitement des vertiges par l'acetyl-l-leucine. | |
BR0311385B1 (pt) | oxatinacarboxamidas, seu processo de preparação e seu emprego, agente e seu processo de preparação, bem como processo para o combate de microorganismos indesejados | |
ATE496047T1 (de) | Phenylen-bis-oxazolidin-derivate und ihre verwendung als antikoagulantien | |
TW200700421A (en) | Novel triazolopyrimidine derivatives | |
ATE553088T1 (de) | Substituierte chinolone ii | |
ATE435868T1 (de) | Homogemcitabine | |
SE0400522D0 (sv) | A medical solution, a method for producing said medical solution and use thereof |